JP2014074015A - Aquaporin production promoter - Google Patents
Aquaporin production promoter Download PDFInfo
- Publication number
- JP2014074015A JP2014074015A JP2013185863A JP2013185863A JP2014074015A JP 2014074015 A JP2014074015 A JP 2014074015A JP 2013185863 A JP2013185863 A JP 2013185863A JP 2013185863 A JP2013185863 A JP 2013185863A JP 2014074015 A JP2014074015 A JP 2014074015A
- Authority
- JP
- Japan
- Prior art keywords
- aquaporin
- acid
- oil
- pearl
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 26
- 102000010637 Aquaporins Human genes 0.000 title claims abstract description 18
- 108010063290 Aquaporins Proteins 0.000 title claims abstract description 15
- 108090000991 Aquaporin 3 Proteins 0.000 claims abstract description 20
- 102000004363 Aquaporin 3 Human genes 0.000 claims abstract description 19
- 239000003531 protein hydrolysate Substances 0.000 claims abstract description 8
- 239000004480 active ingredient Substances 0.000 claims abstract 5
- 238000002360 preparation method Methods 0.000 abstract description 14
- 108010009736 Protein Hydrolysates Proteins 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 239000003921 oil Substances 0.000 description 16
- 235000019198 oils Nutrition 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 230000014509 gene expression Effects 0.000 description 15
- -1 glycerin fatty acid ester Chemical class 0.000 description 14
- 239000011049 pearl Substances 0.000 description 14
- 210000003491 skin Anatomy 0.000 description 12
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 10
- 235000014113 dietary fatty acids Nutrition 0.000 description 10
- 239000000194 fatty acid Substances 0.000 description 10
- 229930195729 fatty acid Natural products 0.000 description 10
- 239000002253 acid Substances 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 238000012360 testing method Methods 0.000 description 7
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 6
- 241000237536 Mytilus edulis Species 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 6
- 235000020638 mussel Nutrition 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 241000490567 Pinctada Species 0.000 description 5
- 238000012790 confirmation Methods 0.000 description 5
- 239000003925 fat Substances 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 238000003753 real-time PCR Methods 0.000 description 5
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 238000000018 DNA microarray Methods 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- 241000255777 Lepidoptera Species 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000010666 rose oil Substances 0.000 description 3
- 235000019719 rose oil Nutrition 0.000 description 3
- 235000015170 shellfish Nutrition 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 2
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 2
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- 239000005770 Eugenol Substances 0.000 description 2
- 239000005792 Geraniol Substances 0.000 description 2
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 235000021360 Myristic acid Nutrition 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 239000004264 Petrolatum Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 241000255969 Pieris brassicae Species 0.000 description 2
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- JBBRZDLNVILTDL-XNTGVSEISA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 16-methylheptadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCC(C)C)C1 JBBRZDLNVILTDL-XNTGVSEISA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 229960005233 cineole Drugs 0.000 description 2
- 239000010630 cinnamon oil Substances 0.000 description 2
- 229940043350 citral Drugs 0.000 description 2
- 229930003633 citronellal Natural products 0.000 description 2
- 235000000983 citronellal Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000011033 desalting Methods 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 229960002217 eugenol Drugs 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 2
- 229940113087 geraniol Drugs 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 235000001510 limonene Nutrition 0.000 description 2
- 229940087305 limonene Drugs 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000004200 microcrystalline wax Substances 0.000 description 2
- 235000019808 microcrystalline wax Nutrition 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 2
- 229940073665 octyldodecyl myristate Drugs 0.000 description 2
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 2
- 229940055577 oleyl alcohol Drugs 0.000 description 2
- 229940056211 paraffin Drugs 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 235000019477 peppermint oil Nutrition 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 229940066842 petrolatum Drugs 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 239000010675 spruce oil Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 229940012831 stearyl alcohol Drugs 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- XULHFMYCBKQGEE-UHFFFAOYSA-N 2-hexyl-1-Decanol Chemical compound CCCCCCCCC(CO)CCCCCC XULHFMYCBKQGEE-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 241000243818 Annelida Species 0.000 description 1
- 102000004391 Aquaporin 6 Human genes 0.000 description 1
- 108090000977 Aquaporin 6 Proteins 0.000 description 1
- 108050006914 Aquaporin 9 Proteins 0.000 description 1
- 102100029464 Aquaporin-9 Human genes 0.000 description 1
- 241000238421 Arthropoda Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 108091006146 Channels Proteins 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- SEBIKDIMAPSUBY-JAUCNNNOSA-N Crocin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O SEBIKDIMAPSUBY-JAUCNNNOSA-N 0.000 description 1
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- ZDQWESQEGGJUCH-UHFFFAOYSA-N Diisopropyl adipate Chemical compound CC(C)OC(=O)CCCCC(=O)OC(C)C ZDQWESQEGGJUCH-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000001293 FEMA 3089 Substances 0.000 description 1
- 241000237858 Gastropoda Species 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- 241000713869 Moloney murine leukemia virus Species 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 241000237988 Patellidae Species 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 238000011530 RNeasy Mini Kit Methods 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 241000736892 Thujopsis dolabrata Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000010620 bay oil Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 1
- 239000001071 citrus reticulata blanco var. mandarin Substances 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 108010006161 conchiolin Proteins 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000001599 crocus sativus l. flower extract Substances 0.000 description 1
- 239000010639 cypress oil Substances 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000010649 ginger oil Substances 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 210000003458 notochord Anatomy 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000007065 protein hydrolysis Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 229940076591 saffron extract Drugs 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Cosmetics (AREA)
Abstract
Description
本発明は、アクアポリン特にアクアポリン3の産生を促進し、皮膚を健全に保つ製剤に関する。 The present invention relates to a preparation that promotes the production of aquaporin, particularly aquaporin 3, and keeps the skin healthy.
アクアポリンとは細胞膜に存在する細孔を持ったタンパク質であり、水分子を選択的に透過させるが、イオンや他の物質は透過させない水チャネル(water channel)と呼ばれている。アクアポリンは普通4つの同一サブユニットで構成されており、それぞれのモノマーが水チャネルとして働いている。水分子はこのチャネルの細孔を通過する。この水チャネルが働くことで水の細胞膜透過性が上がっている。人間の多くの細胞、ある種のバクテリア、さらに植物のような有機生命体にとってこのような水分子を輸送するシステムが不可欠である。
ヒトでは、13種類のアクアポリン(0〜12)の存在が知られている。表皮細胞においては、主としてアクアポリン3が存在しており、水に加えて、水分保持作用に関与するグリセロールや尿素等の低分子化合物をも取り込む役割を担っていると考えられている。
Aquaporin is a protein with pores present in the cell membrane, and is called a water channel that selectively permeates water molecules but does not permeate ions and other substances. Aquaporins are usually composed of four identical subunits, each monomer acting as a water channel. Water molecules pass through the pores of this channel. This water channel works to increase the cell membrane permeability of water. Systems that transport such water molecules are essential for many human cells, certain bacteria, and organic organisms such as plants.
In humans, the presence of 13 types of aquaporins (0 to 12) is known. In epidermal cells, aquaporin 3 is mainly present, and it is considered to play a role of taking in low molecular compounds such as glycerol and urea involved in water retention action in addition to water.
皮膚にはアクアポリンの中でもアクアポリン3が存在することが知られており、アクアポリン3の欠損マウスでは皮膚の水分量や弾力が顕著に低下することが報告されている。又、アクアポリン3欠損マウスでは傷の治りが遅延することも報告されている。このようにアクアポリンは、皮膚の水分や弾力を恒常的に維持することに不可欠であり、肌荒れ等の創傷を負った場合の回復能にも大きな影響を及ぼしていることからアクアポリンの産生を増強することで、様々な皮膚トラブルを改善できると考えられてきた。
天然物ではサフランの抽出物、ローヤルゼリー抽出物、ブッチャーズブルーム抽出物等がアクアポリン3産生促進剤として知られている。(特許文献1〜3)
It is known that aquaporin 3 is present in the skin among aquaporins, and it has been reported that in mice lacking aquaporin 3, the water content and elasticity of the skin are significantly reduced. It has also been reported that wound healing is delayed in aquaporin 3-deficient mice. In this way, aquaporins are essential for maintaining the moisture and elasticity of the skin constantly, and have a significant impact on the ability to recover when wounded, such as rough skin. Thus, it has been considered that various skin problems can be improved.
Among natural products, saffron extract, royal jelly extract, butcher's bloom extract and the like are known as aquaporin 3 production promoters. (Patent Documents 1 to 3)
真珠や真珠層由来蛋白加水分解物は加水分解コンキオリンとして化粧品に古くより、利用されており、例えば、ヒスタミン抑制、活性酸素抑制等の効果が知られている。
本発明の目的はアクアポリン、特にアクアポリン3の産生を促進し、皮膚を健全に保つ製剤を得ることである。 An object of the present invention is to obtain a preparation that promotes the production of aquaporins, particularly aquaporin 3, and keeps the skin healthy.
本発明者らが鋭意検討した結果、真珠及び/又は真珠層由来蛋白加水分解物が上記目的を達することがわかった。
ここで利用する真珠及び真珠層について説明する。
まず、真珠とは,生きた真珠貝の中で球状または半球状(多少の変形を含む)に形成される代謝生産物であって,かつ,この外見しうる部分の主たる構成物質が,真珠貝の真珠層と等質であるものをいう。
真珠貝は貝殻に真珠層を有する貝類をいうが、二枚貝綱、腹足綱、頭足綱などのうち特定の古い系統の貝類を指し、例示すれば、アコヤガイ、シロチョウガイ、クロチョウガイ、ベニコチョウガイ、マベガイ等のアコヤガイ属の二枚貝類の他に、イガイ、ムラサキイガイ、ヤコウガイ、イケチョウガイ、カワシンジュガイ、カサガイ等が挙げられる。
このうち、アコヤガイ、シロチョウガイ、クロチョウガイが養殖も実施されており原料の確保の点から好ましい。
真珠はそのままか或いは核を取り除く。
真珠層を有する貝殻を利用する場合は貝殻に付着した、触手動物、軟体動物、節足動物、環形動物、脊索動物、海藻類等々多種多様の生物や海泥等の無機物を、水、ブラシ、ヘラ等で取り除く。(勿論貝肉等もなるべく取り除いておく)
また、貝殻の内、殻皮層、稜柱層は場合によっては、ブラシ、ヘラ、グラインダーを用いて取り除く。また、特開昭62−120319号公報、特開2003−250489号公報、特開2011−72207号公報等にも種々の方法が記載されているので任意の方法を選択すればよい。
以上、真珠或いは真珠層を有する貝殻の一方又は両方より、炭酸カルシウム等を除くために脱灰する。これをスムーズに行うために破砕・粉砕工程を必要に応じて加える。
破砕・粉砕は、金槌、棒等で破砕してもよいし、ジャイレトリクラッシャー 、コーンクラッシャー、シングルロールクラッシャー、ダブルロールクラッシャー 、インパクトクラッシャー、ボールミル、ハンマーミル、ロッドミル等のクラッシャーや粉砕機を用いて破砕・粉砕を行ってもよい。
As a result of intensive studies by the present inventors, it has been found that a pearl and / or a protein hydrolyzate derived from a pearl layer achieves the above object.
The pearl and nacre used here will be described.
First, a pearl is a metabolite formed in a spherical or hemispherical shape (including some deformations) in a living pearl shell, and the main constituent of this visible portion is a pearl shell. This is the same quality as the pearl layer.
A pearl oyster is a shell with a nacre in its shell, but it refers to a specific old family of shells such as bivalves, gastropods, cephalopods, etc., for example, pearl oysters, white butterflies, black butterflies, black butterflies In addition to bivalves belonging to the genus Akoya, such as mussels, mussels, mussels, mussels, butterflies, kawashinjugai, limpets and the like can be mentioned.
Among these, pearl oysters, white butterflies, and black oysters are also cultivated and are preferable from the viewpoint of securing raw materials.
The pearl is left as it is or the nucleus is removed.
When using a shell with a nacreous layer, minerals such as tentacles, mollusks, arthropods, annelids, notochords, seaweeds, etc. attached to the shell, such as water, brushes, Remove with a spatula. (Of course, remove as much shellfish as possible)
Further, in some cases, the shell layer, the shell layer, and the ridge column layer are removed using a brush, a spatula, and a grinder. Also, since various methods are described in JP-A-62-120319, JP-A-2003-250489, JP-A-2011-72207, etc., any method may be selected.
As mentioned above, it deashes in order to remove a calcium carbonate etc. from one or both of the shell which has a pearl or a pearl layer. In order to perform this smoothly, a crushing and crushing process is added as necessary.
The crushing and crushing may be performed with a hammer, a rod, etc., or using a crusher or crusher such as a gyratory crusher, cone crusher, single roll crusher, double roll crusher, impact crusher, ball mill, hammer mill or rod mill. You may crush and grind | pulverize.
脱灰は通常酸を用いて行われる。用いる酸は、カルシウムと反応して水に溶解するものであれば用いることができる。例示すれば、塩酸、硝酸、乳酸、酢酸、グリコール酸等の無機酸、有機酸を挙げることができるが、なかでもコストの面から塩酸が選択される場合が多い。塩酸を使用するときは発泡するので、必要に応じて、水を加えて、徐々に塩酸を加えながら撹拌する。撹拌は加えた水の量、貝殻の粉砕程度、反応温度、発砲の程度等によって撹拌の強度を選択する。
また、反応時間は粉砕の程度、反応温度等によって変化するが、10時間〜10日間程度が好ましい。
加える塩酸の量は炭酸カルシウムが溶解する程度でよいが、後工程の蛋白の加水分解工程で酸を用いる場合は加水分解時の酸濃度が変化するので、塩酸の量は炭酸カルシウムが溶解するに必要な量より若干多めにし、充分に脱灰しておく。
これを遠心分離、濾過等で不溶物を集める。用途によっては後述する脱塩工程を実施する場合、脱塩の方法によってはこの工程で充分に塩を取り除く必要があるので、不溶物に水を加えて、撹拌後、遠心分離、濾過等で不溶物を集める工程を複数回繰り返すとよい。
Decalcification is usually performed using an acid. Any acid can be used as long as it reacts with calcium and dissolves in water. For example, inorganic acids and organic acids such as hydrochloric acid, nitric acid, lactic acid, acetic acid, and glycolic acid can be mentioned. Of these, hydrochloric acid is often selected from the viewpoint of cost. When hydrochloric acid is used, it foams. If necessary, add water and stir while gradually adding hydrochloric acid. Agitation is selected according to the amount of water added, the degree of shell crushing, the reaction temperature, the degree of firing, and the like.
The reaction time varies depending on the degree of pulverization, reaction temperature and the like, but is preferably about 10 hours to 10 days.
The amount of hydrochloric acid to be added may be such that calcium carbonate dissolves. However, when acid is used in the protein hydrolysis step in the subsequent step, the acid concentration during hydrolysis changes, so the amount of hydrochloric acid dissolves calcium carbonate. Slightly more than necessary and decalcify well.
Insoluble matters are collected by centrifugation, filtration, and the like. Depending on the application, when performing the desalting step described later, depending on the desalting method, it is necessary to remove the salt sufficiently in this step, so add water to the insoluble matter, stir, then insoluble by centrifugation, filtration, etc. The process of collecting things may be repeated multiple times.
集めた不溶物を加水分解する。加水分解の方法は酸、アルカリ、蛋白分解酵素等を用いて行うが、真珠或いは真珠層の蛋白は通常の蛋白分解酵素では分解できないので、酵素の種類、分解条件を工夫する必要がある。
酸としては、硫酸、塩酸、硝酸、リン酸、亜硫酸、シュウ酸、クエン酸、酢酸、ギ酸、乳酸などが使用でき、アルカリとしては、水酸化ナトリウム、水酸化カリウム等が例示されるが、このうちの1種又は2種以上を用いて、さらには蛋白分解酵素と組み合わせて蛋白を加水分解する。この中でもよく用いられるのは、塩酸、硫酸が挙げられる。
加水分解の条件は、酸、アルカリ、酵素の種類によって選択されるが、塩酸や硫酸を用いる場合は、1〜10モル、室温〜120℃、1時間〜10日間程度がよく、加圧も加えてもよい。
加水分解後、酸やアルカリを用いた場合は中和、酵素を用いた場合は加熱等の失活操作を必要に応じて行う。さらに用途によっては、完全に或いは一部脱塩する。
その後、必要に応じて脱色工程や乾燥工程を加え、真珠及び/又は真珠層由来蛋白加水分解物を得る。
また、特開昭62−223104号公報、特開平02−076597号公報、特開平05−043444号公報の方法も参考になる。
The collected insoluble matter is hydrolyzed. Hydrolysis is carried out using acid, alkali, proteolytic enzyme, etc., but pearls or nacreous proteins cannot be decomposed by ordinary proteolytic enzymes, so it is necessary to devise the type of enzyme and the decomposition conditions.
Examples of the acid include sulfuric acid, hydrochloric acid, nitric acid, phosphoric acid, sulfurous acid, oxalic acid, citric acid, acetic acid, formic acid, and lactic acid. Examples of the alkali include sodium hydroxide and potassium hydroxide. The protein is hydrolyzed using one or more of them, and further in combination with a protease. Of these, hydrochloric acid and sulfuric acid are often used.
Hydrolysis conditions are selected according to the type of acid, alkali, and enzyme, but when hydrochloric acid or sulfuric acid is used, 1 to 10 mol, room temperature to 120 ° C., about 1 hour to 10 days is good, and pressure is also applied. May be.
After the hydrolysis, neutralization is performed as necessary when acid or alkali is used, and deactivation such as heating is performed as necessary when an enzyme is used. Further, depending on the application, the salt is completely or partially desalted.
Then, a decolorization process and a drying process are added as needed, and a pearl and / or a pearl layer origin protein hydrolyzate are obtained.
Further, the methods disclosed in JP-A-62-2223104, JP-A-02-075597, and JP-A-05-043444 are also helpful.
本発明の製剤は、経口、注射、外用のいずれでも薬効を発現するが、皮膚外用剤として用いるのが好ましい。皮膚外用剤には、皮膚化粧料、外用医薬部外品、医療用皮膚外用剤が含まれる。 The preparation of the present invention exhibits drug efficacy for oral, injection, and external use, but is preferably used as a skin external preparation. Skin external preparations include skin cosmetics, external quasi-drugs, and medical skin external preparations.
また、本発明の製剤には、上記成分の他に医薬品や化粧品の各種製剤において使用されている界面活性剤、油性成分、保湿剤、高分子化合物、紫外線吸収剤、抗炎症剤、殺菌剤、酸化防止剤、金属イオン封鎖剤、防腐剤、ビタミン類、色素、香料、水等を配合することができる。 In addition to the above ingredients, the preparations of the present invention include surfactants, oily ingredients, moisturizers, polymer compounds, ultraviolet absorbers, anti-inflammatory agents, bactericides, and other agents used in various pharmaceutical and cosmetic preparations. Antioxidants, sequestering agents, preservatives, vitamins, pigments, fragrances, water and the like can be blended.
上記界面活性剤としては、アニオン性、カチオン性、非イオン性、天然、合成のいずれの界面活性剤も使用できるが、皮膚に対する刺激性を考慮すると非イオン性のものを使用することが好ましい。非イオン性界面活性剤としては、例えばグリセリン脂肪酸エステル、プロピレングリコール脂肪酸エステル、ソルビタン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレンソルビット脂肪酸エステル、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンポリオキシプロピレングリコール、ポリオキシエチレンポリオキシプロピレンアルキルエーテル、ポリエチレングリコール脂肪酸エステル、ポリオキシエチレンヒマシ油、ポリオキシエチレン硬化ヒマシ油、アルキルグリコシド等が挙げられる。 As the surfactant, any of anionic, cationic, nonionic, natural, and synthetic surfactants can be used, but it is preferable to use a nonionic surfactant in consideration of irritation to the skin. Examples of the nonionic surfactant include glycerin fatty acid ester, propylene glycol fatty acid ester, sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene sorbite fatty acid ester, polyoxyethylene alkyl ether, polyoxyethylene polyoxypropylene glycol. , Polyoxyethylene polyoxypropylene alkyl ether, polyethylene glycol fatty acid ester, polyoxyethylene castor oil, polyoxyethylene hydrogenated castor oil, alkylglycoside and the like.
油性成分としては、油脂類、ロウ類、炭化水素類、高級脂肪酸類、高級アルコール類、エステル類、精油類、シリコーン油類などを挙げることができる。油脂類としては、例えば大豆油、ヌカ油、ホホバ油、アボガド油、アーモンド油、オリーブ油、カカオ油、ゴマ油、パーシック油、ヒマシ油、ヤシ油、ミンク油、牛脂、豚脂等の天然油脂、これらの天然油脂を水素添加して得られる硬化油及びミリスチン酸グリセリド、2−エチルヘキサン酸トリグリセリド等の合成トリグリセリド等が;ロウ類としては、例えばカルナバロウ、鯨ロウ、ミツロウ、ラノリン等が;炭化水素類としては、例えば流動パラフィン、ワセリン、パラフィンマイクロクリスタリンワックス、セレシン、スクワラン、ブリスタン等が;高級脂肪酸類としては、例えばラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘニン酸、オレイン酸、リノール酸、リノレン酸、ラノリン酸、イソステアリン酸等が;高級アルコール類としては、例えばラウリルアルコール、セチルアルコール、ステアリルアルコール、オレイルアルコール、ラノリンアルコール、コレステロール、2−ヘキシルデカノール等が;エステル類としては、例えばオクタン酸セチル、オクタン酸トリグリセライド、乳酸ミリスチル、乳酸セチル、ミリスチン酸イソプロピル、ミリスチン酸ミリスチル、ミリスチン酸オクチルドデシル、パルミチン酸イソプロピル、アジピン酸イソプロピル、ステアリン酸ブチル、オレイン酸デシル、イソステアリン酸コレステロール、POEソルビット脂肪酸エステル等が;精油類としては、例えばハッカ油、ジャスミン油、ショウ脳油、ヒノキ油、トウヒ油、リュウ油、テレピン油、ケイ皮油、ベルガモット油、ミカン油、ショウブ油、パイン油、ラベンダー油、ベイ油、クローブ油、ヒバ油、バラ油、ユーカリ油、レモン油、タイム油、ペパーミント油、ローズ油、セージ油、メントール、シネオール、オイゲノール、シトラール、シトロネラール、ボルネオール、リナロール、ゲラニオール、カンファー、チモール、スピラントール、ピネン、リモネン、テルペン系化合物等が;シリコーン油類としては、例えばジメチルポリシロキサン等が挙げられる。これら上述の油性成分は一種又は二種以上を組み合わせて使用することができる。本発明においては、このうち特にミリスチン酸グリセリド、2−エチルヘキサン酸トリグリセリド、ラノリン、流動パラフィン、ワセリン、パラフィンマイクロクリスタリンワックス、スクワラン、ラウリン酸、ミリスチン酸、パルミチン酸、リノール酸、リノレン酸、イソステアリン酸、セチルアルコール、ステアリルアルコール、オレイルアルコール、コレステロール、オクタン酸セチル、オクタン酸トリグリセライド、ミリスチレン酸イソプロピル、ミリスチン酸オクチルドデシル、イソステアリン酸コレステロール、POEソルビット脂肪酸エステル、ハッカ油、トウヒ油、ケイ皮油、ローズ油、メントール、シネオール、オイゲノール、シトラール、シトロネラール、ゲラニオール、ピネン、リモネン、ジメチルポリシロキサンを使用することが好ましい。 Examples of the oil component include fats and oils, waxes, hydrocarbons, higher fatty acids, higher alcohols, esters, essential oils, silicone oils, and the like. Examples of the fats and oils include soybean oil, nutka oil, jojoba oil, avocado oil, almond oil, olive oil, cacao oil, sesame oil, persic oil, castor oil, coconut oil, mink oil, beef fat, pork fat and the like, and these Hardened oil obtained by hydrogenation of natural fats and oils and synthetic triglycerides such as myristic acid glyceride and 2-ethylhexanoic acid triglyceride; waxes include, for example, carnauba wax, whale wax, beeswax, lanolin and the like; hydrocarbons For example, liquid paraffin, petrolatum, paraffin microcrystalline wax, ceresin, squalane, bristan etc .; higher fatty acids include, for example, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, linoleic acid, Linolenic acid, lanolinic acid, isostearic acid, etc .; Examples of the class alcohols include lauryl alcohol, cetyl alcohol, stearyl alcohol, oleyl alcohol, lanolin alcohol, cholesterol, 2-hexyldecanol, etc .; examples of the esters include cetyl octanoate, triglyceride octanoate, myristyl lactate, cetyl lactate, Examples of essential oils include mint oil, jasmine, isopropyl myristate, myristyl myristate, octyldodecyl myristate, isopropyl palmitate, isopropyl adipate, butyl stearate, decyl oleate, cholesterol isostearate, POE sorbite fatty acid ester, etc. Oil, pepper brain oil, cypress oil, spruce oil, ryu oil, turpentine oil, cinnamon oil, bergamot oil, mandarin oil, ginger oil, pine , Lavender oil, bay oil, clove oil, hiba oil, rose oil, eucalyptus oil, lemon oil, thyme oil, peppermint oil, rose oil, sage oil, menthol, cineole, eugenol, citral, citronellal, borneol, linalool, geraniol, Camphor, thymol, spirantol, pinene, limonene, terpene compounds, etc .; examples of silicone oils include dimethylpolysiloxane. These oily components described above can be used alone or in combination of two or more. In the present invention, among these, myristic acid glyceride, 2-ethylhexanoic acid triglyceride, lanolin, liquid paraffin, petrolatum, paraffin microcrystalline wax, squalane, lauric acid, myristic acid, palmitic acid, linoleic acid, linolenic acid, isostearic acid , Cetyl alcohol, stearyl alcohol, oleyl alcohol, cholesterol, cetyl octanoate, triglyceride octanoate, isopropyl myristate, octyldodecyl myristate, cholesterol isostearate, POE sorbite fatty acid ester, peppermint oil, spruce oil, cinnamon oil, rose Oil, menthol, cineol, eugenol, citral, citronellal, geraniol, pinene, limonene, dimethylpolysiloxane It is preferable to use.
本発明の製剤には、さらに下記のような成分を配合することができるが、その成分もこれらに限定されるものではない。
色素類;黄色4号、青色1号、黄色202号等の厚生省令に定められたタール色素別表I及びIIの色素、クロロフィル、リボフラビン、クロシン、紅花、アントラキノン等の食品添加物として認められている天然色素等。
ビタミン類;ビタミンA、ビタミンC、ビタミンD、ビタミンE等。
その他;殺菌剤、防腐剤、その他製剤上必要な成分等。
The following components can be further added to the preparation of the present invention, but the components are not limited thereto.
Colors: Yellow color No. 4, Blue No. 1 and Yellow No. 202 are recognized as food additives such as tar color dyes I and II, chlorophyll, riboflavin, crocin, safflower, anthraquinone, etc. Natural pigments.
Vitamins; vitamin A, vitamin C, vitamin D, vitamin E, etc.
Others: bactericides, preservatives, other ingredients necessary for formulation.
本発明の製剤は、前記必須成分に必要に応じて前記任意成分を加え、常法に従って製造することができ、クリーム、乳液、化粧水等の形態とすることができる。 The preparation of the present invention can be produced according to a conventional method by adding the optional components to the essential components as necessary, and can be in the form of cream, emulsion, lotion or the like.
次に実施例(製造例)を挙げて本発明を詳細に説明する。 Next, an Example (manufacturing example) is given and this invention is demonstrated in detail.
製造例1
貝肉や貝殻に付着物を水、ブラシで除去し、約1〜5mm程度に粉砕したアコヤガイ貝殻50kgに水450kgを加えて撹拌しつつ、塩酸100kgを徐々に加えた。さらに水100kgを加え3日間撹拌した。塩酸10kgを徐々に加えた。さらに水200kgを加え2日間撹拌した。撹拌しつつ、水酸化ナトリウム3kgを徐々に加えた。
pH7になるように25%水酸化ナトリウムで調整した後水200kg加えた。これをシャープレス遠心機で沈殿を集めた。
沈殿を解砕し、0.1モル塩酸20kgを加えて24日間ゆっくり撹拌した。これに水1000kgを撹拌しつつ加えたのち、シャープレス遠心機で沈殿を集めた。
沈殿を解砕し、これに水1000kgを撹拌しつつ加えたのち、シャープレス遠心機で沈殿を集めた。
この沈殿200gに10倍希釈した硫酸を3kg加え、110℃のオイルバスで24時間加水分解した。
放冷後、水酸化バリウムを徐々に加えながらpH3.0に調整した後、遠心分離(6000rpm、15分間)し、上澄みにアンバーライトIRA910をpH7.0になるまで徐々に加えた。これを濾過して濾液に活性炭を10g加え30分間撹拌した。
これを濾過し、凍結乾燥した。
Production Example 1
Deposits were removed from the shellfish and shells with water and a brush, and 450 kg of water was added to 50 kg of pearl oyster shells crushed to about 1 to 5 mm, and 100 kg of hydrochloric acid was gradually added. Further, 100 kg of water was added and stirred for 3 days. Hydrochloric acid 10 kg was gradually added. Further, 200 kg of water was added and stirred for 2 days. While stirring, 3 kg of sodium hydroxide was gradually added.
After adjusting the pH to 25 with sodium hydroxide 25%, 200 kg of water was added. The precipitate was collected with a sharp press centrifuge.
The precipitate was crushed, 20 kg of 0.1 molar hydrochloric acid was added, and the mixture was slowly stirred for 24 days. To this was added 1000 kg of water with stirring, and the precipitate was collected with a sharp press centrifuge.
The precipitate was crushed and 1000 kg of water was added to this with stirring, and then the precipitate was collected with a sharp press centrifuge.
To 200 g of this precipitate, 3 kg of 10-fold diluted sulfuric acid was added and hydrolyzed in an oil bath at 110 ° C. for 24 hours.
After allowing to cool, the pH was adjusted to 3.0 while gradually adding barium hydroxide, and then centrifuged (6000 rpm, 15 minutes), and Amberlite IRA910 was gradually added to the supernatant until the pH reached 7.0. This was filtered, 10 g of activated carbon was added to the filtrate, and the mixture was stirred for 30 minutes.
This was filtered and lyophilized.
製造例2
貝肉や貝殻に付着物を水、ブラシで除去し、約1〜5mm程度に粉砕したクロチョウガイ貝殻5kgに水45kgを加えて撹拌しつつ、塩酸10kgを徐々に加えた。さらに水10kgを加え3日間撹拌した。塩酸1kgを徐々に加えた。さらに水200kgを加え2日間撹拌した。撹拌しつつ、水酸化ナトリウム300gを徐々に加えた。
10%硫酸500gを加え、110℃のオイルバスで24時間加水分解した。
放冷後、水酸化ナトリウムを徐々に加えながらpH7.0に調整した後、遠心分離(6000rpm、15分間)し、上澄みを得た。これに2倍量のエタノールを加え、ゆっくり撹拌した後、4℃で1週間静置した。
これを濾過し、凍結乾燥した。
Production Example 2
Deposits were removed from the shellfish and shells with water and a brush, and 45 kg of water was added to 5 kg of black mussel shells crushed to about 1 to 5 mm, and 10 kg of hydrochloric acid was gradually added. Further, 10 kg of water was added and stirred for 3 days. 1 kg of hydrochloric acid was gradually added. Further, 200 kg of water was added and stirred for 2 days. While stirring, 300 g of sodium hydroxide was gradually added.
500 g of 10% sulfuric acid was added and hydrolyzed in an oil bath at 110 ° C. for 24 hours.
After allowing to cool, the pH was adjusted to 7.0 while gradually adding sodium hydroxide, and then centrifuged (6000 rpm, 15 minutes) to obtain a supernatant. Two times the amount of ethanol was added thereto, and the mixture was slowly stirred and allowed to stand at 4 ° C. for 1 week.
This was filtered and lyophilized.
確認試験1 DNAマイクロアレイ解析
試験方法は、製造例1の0.5%を表皮ケラチノサイトに作用して48時間後に上記(RealTimePCR)と同様にしてコントロールと共にRNAを抽出し、各3μgのRNAからQuick Amp Labeling Kit, two−color(Agilent Technologies)を用いてCy3,Cy5標識プローブを作成した。Quiagen RNeasy mini kit(Quiagen)を用いて標識プローブを精製後、Gene Expression Hybridization kit(Agilent Technologies)を用いてWhole Human Genomeスライド(4×44K, Agilent Technologies)上で60℃、17時間ハイブリダイズした。洗浄後、Agilent DNA microarray scanner(Agilent Technologies)を用いてスキャンし、Feature Extraction softwareを使ってデータ処理を行った。
Confirmation test 1 DNA microarray analysis In the test method, 0.5% of Production Example 1 was allowed to act on epidermal keratinocytes, 48 hours later, RNA was extracted together with the control in the same manner as above (RealTime PCR), and Quick Amp was used from 3 μg of each RNA. Cy3 and Cy5 labeled probes were prepared using Labeling Kit, two-color (Agilent Technologies). After purification of the labeled probe using a Qiagen RNeasy mini kit (Qiagen), it was performed using a Gene Expression Hybridization kit (Agilent Technologies) at a Whole Human Genome slide (4 × 44 K, at an electron temperature of 60 ° C., at 17 ° C., at 17 ° C., at a temperature of 17 ° C., at a temperature of 17 ° C. After washing, scanning was performed using an Agilent DNA microarray scanner (Agilent Technologies), and data processing was performed using Feature Extraction software.
試験結果は、Log Ratioとして、アクアポリン3は0.469、アクアポリン6は0.816、アクアポリン9は0.376となった。 The test results were as Log Ratio, aquaporin 3 was 0.469, aquaporin 6 was 0.816, and aquaporin 9 was 0.376.
確認試験2
2継代目のヒト包皮由来表皮細胞(クラボウ)を50−70%コンフルエントとなるようHuMedia−KG2培地(フェノールレッド不含)で培養後、前日にカルシウム濃度を1.8mMに変更したHuMedia−KG2培地に、製造例を添加し、37℃、5%CO2インキュベータ中で2日間培養した。
Confirmation test 2
The second passage human foreskin-derived epidermis cells (Kurabo) were cultured in HuMedia-KG2 medium (without phenol red) so as to be 50-70% confluent, and then the media concentration was changed to 1.8 mM on the previous day, HuMedia-KG2 medium. Then, the preparation example was added, and the cells were cultured at 37 ° C. in a 5% CO 2 incubator for 2 days.
<RNAの抽出>
細胞からの Total RNAの抽出は、トリプシン/EDTAで剥離後、SV Total RNA Isolation System(プロメガ社)を用い、プロメガ社の添付マニュアル(日本語プロトコールNoTM048J2001年6月作成)に従い調製した。RNA濃度は、NanoDrop1000(Thermo SCIENTIFIC)を用い算出した。
<Extraction of RNA>
Total RNA was extracted from the cells after peeling with trypsin / EDTA and using SV Total RNA Isolation System (Promega) according to the manual attached to Promega (prepared in Japanese protocol NoTM048J, June 2001). The RNA concentration was calculated using NanoDrop1000 (Thermo SCIENTIFIC).
<RT反応およびリアルタイムPCR>
2.5μgのTotal RNAを使い、MMLV Reverse Transcriptase RNaseH−(東洋紡社)を用い、東洋紡社推奨プロトコール(TOYOBO BIOCHEMICALS FOR LIFE SCIENCE 2008/2009のページ1−42)に従いRT反応を行なった。
リアルタイムPCRはAppliedBiosystems 7500 リアルタイムPCR Systemを用い、以下のように実施した。SYBR Green法を用い(THUNDERBIRD SYBR qPCR Mix,東洋紡社)、7500 リアルタイムPCR Systemの操作マニュアル(AppliedBiosystems)を用いて、Comparative CT(△△CT)法(n=3)により遺伝子発現比較を実施した。内部標準としてGAPDHを使用した。
<RT reaction and real-time PCR>
Using 2.5 μg of total RNA, RT reaction was performed according to Toyobo recommended protocol (TOYOBO BIOCHEMICALS FOR LIFE SCIENCE 2008/2009, page 1-42) using MMLV Reverse Transcriptase RNase H- (Toyobo).
Real-time PCR was performed as follows using Applied Biosystems 7500 Real-Time PCR System. Using the SYBR Green method (THUNDERBIRD SYBR qPCR Mix, Toyobo Co., Ltd.) and the 7500 Real-Time PCR System operation manual (Applied Biosystems), gene expression comparison was performed by the Comparative CT (ΔΔCT) method (n = 3). GAPDH was used as an internal standard.
<使用プライマー>
AQP3:フォワードプライマーがAGACAGCCCCTTCAGGATTT(配列番号1)の塩基配列と、リバースプライマーがTTCCCTTGCCCTGAATATCTG(配列番号2)の塩基配列とのセット
GAPDH:フォワードプライマーがGAGTCAACGGATTTGGTCGT(配列番号3)の塩基配列と、リバースプライマーがTTGATTTTGGAGGGATCTCG(配列番号4)の塩基配列とのセット
<Primer used>
AQP3: A set of a forward primer is AGAGCCCCCTTCAGGATTTT (SEQ ID NO: 1) and a reverse primer is TTCCCTTGCCCTGAATATCTG (SEQ ID NO: 2) Set with the base sequence of TTGATTTTGGAGGGATCTCG (SEQ ID NO: 4)
確認試験2の結果は、製造例1を0.5%作用させて実験した結果を図1に示す。
結果を見ると、製造例1は0.5%で作用させた場合、アクアポリン3の遺伝子発現量を約4.0倍に増加させることがわかった。
次に、製造例2を0.5%作用させて実験した結果を図2に示す。
結果を見ると、製造例2は0.5%で作用させた場合、アクアポリン3の遺伝子発現量を約2.2倍に増加させることがわかった。
The result of the confirmation test 2 is shown in FIG.
From the results, it was found that Production Example 1 increased the gene expression level of aquaporin 3 by about 4.0 times when acting at 0.5%.
Next, FIG. 2 shows the results of an experiment conducted with Production Example 2 acting at 0.5%.
From the results, it was found that Production Example 2 increased the gene expression level of aquaporin 3 by about 2.2 times when acting at 0.5%.
このように、アコヤガイ由来の製造例1は、DNAマイクロアレイ解析で、アクアポリン3,6,9の各遺伝子の発現を促進することが示された。
さらに、定量的なmRNA遺伝子発現試験で、アクアポリン3の遺伝子の発現を確認したところ、遺伝子の発現を促進することを確認した。
また、クロチョウガイ由来の製造例2でもアクアポリン3の遺伝子の発現を促進することを確認した。
As described above, Production Example 1 derived from the pearl oyster was shown to promote the expression of each gene of aquaporins 3, 6, and 9 by DNA microarray analysis.
Furthermore, when the expression of the aquaporin 3 gene was confirmed by a quantitative mRNA gene expression test, it was confirmed that the gene expression was promoted.
Moreover, it confirmed that the expression of the gene of aquaporin 3 was promoted also in the manufacture example 2 derived from the black mussel.
また、製造例を配合した外用剤を作成し、実際に使用してみた結果、アクアポリン、特にアクアポリン3の産生を促進し、みずみずしい皮膚を得られることがわかった。 In addition, as a result of preparing and actually using an external preparation blended with production examples, it was found that the production of aquaporin, particularly aquaporin 3, was promoted, and fresh skin was obtained.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013185863A JP2014074015A (en) | 2012-09-13 | 2013-09-09 | Aquaporin production promoter |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012201500 | 2012-09-13 | ||
JP2012201500 | 2012-09-13 | ||
JP2013185863A JP2014074015A (en) | 2012-09-13 | 2013-09-09 | Aquaporin production promoter |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2014074015A true JP2014074015A (en) | 2014-04-24 |
Family
ID=50748464
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013185863A Pending JP2014074015A (en) | 2012-09-13 | 2013-09-09 | Aquaporin production promoter |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2014074015A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07165526A (en) * | 1993-12-13 | 1995-06-27 | Mikimoto Pharmaceut Co Ltd | Cosmetic material and its production |
JP2010105925A (en) * | 2008-10-28 | 2010-05-13 | Juntendo | Skin keratinization-promoting agent |
JP2011148732A (en) * | 2010-01-21 | 2011-08-04 | Maruzen Pharmaceut Co Ltd | Aquaporin 3 production promoter |
WO2012115947A2 (en) * | 2011-02-22 | 2012-08-30 | Akzo Nobel Chemicals International B.V. | Composition comprising banyan tree, lotus, and clover serum fractions (aging) |
JP2012161273A (en) * | 2011-02-07 | 2012-08-30 | Nippon Menaade Keshohin Kk | Method for evaluating capability of skin in retaining moisture under epidermis |
-
2013
- 2013-09-09 JP JP2013185863A patent/JP2014074015A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07165526A (en) * | 1993-12-13 | 1995-06-27 | Mikimoto Pharmaceut Co Ltd | Cosmetic material and its production |
JP2010105925A (en) * | 2008-10-28 | 2010-05-13 | Juntendo | Skin keratinization-promoting agent |
JP2011148732A (en) * | 2010-01-21 | 2011-08-04 | Maruzen Pharmaceut Co Ltd | Aquaporin 3 production promoter |
JP2012161273A (en) * | 2011-02-07 | 2012-08-30 | Nippon Menaade Keshohin Kk | Method for evaluating capability of skin in retaining moisture under epidermis |
WO2012115947A2 (en) * | 2011-02-22 | 2012-08-30 | Akzo Nobel Chemicals International B.V. | Composition comprising banyan tree, lotus, and clover serum fractions (aging) |
Non-Patent Citations (1)
Title |
---|
J. B. C., vol. 277(48), JPN6017020876, 2002, pages 46616 - 21, ISSN: 0003574359 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6744079B2 (en) | Caspase-14 expression promoter | |
JP6474058B2 (en) | Endothelin-1 production inhibitor | |
JP2014074016A (en) | Metallothionein production promoter | |
JP2014074015A (en) | Aquaporin production promoter | |
JP2018002704A (en) | Filaggrin production promoter, involucrin production promoter, loricrin production promoter, and corneo-desmosin production promoter | |
JP2018035145A (en) | Filaggrin production promoter, involucrin production promoter, loricrin production promoter, histidase production promoter, and sprr1b production promoter | |
JP6242849B2 (en) | Kallikrein-related peptidase production promoter, LEKTI production promoter, SLPI production promoter, keratinization normalizing agent, corneodesmosome degradation normalizing agent | |
JP6173844B2 (en) | Hyaluronic acid synthesis accelerator | |
JP2021169532A (en) | Transglutaminase production promoter | |
JP6970952B2 (en) | Kallikrein-related peptidase production promoter, LEKTI production promoter, SLPI production promoter, keratinization normalizer, corneodesmosome degradation normalizer | |
JP2002037742A (en) | Skin care preparation | |
JP2014040398A (en) | Filaggrin production accelerator, involucrin production accelerator, loricrin production accelerator, corneo-desmosin production accelerator, and others | |
JP2014088368A (en) | Involucrin production promoter and skin barrier function reinforcing agent | |
JP6480134B2 (en) | Cosmetics | |
JP6769705B2 (en) | How to make placenta extract | |
JP2018002703A (en) | Psoriasin production promoter | |
JP2016135769A (en) | Claudin production-promoting agent, occludin production-promoting agent, and tight junction function-enhancing agent | |
JP2018035144A (en) | Filaggrin production promoter | |
JP6480133B2 (en) | Claudin production promoter, tight junction function enhancer | |
JP6356944B2 (en) | Claudin production promoter, occludin production promoter, tight junction function enhancer | |
JP2014101309A (en) | Cystatin a production promoter, skin barrier increasing agent, skin keratinization function increasing agent, and skin roughness preventing agent | |
JP6029875B2 (en) | Collagen production promoter | |
JP7021762B2 (en) | Kallikrein-related peptidase production promoter, LEKTI production promoter, SLPI production promoter, keratinization normalizer, corneodesmosome degradation normalizer | |
JP2017132761A (en) | Psoriasin production promoter | |
JP6716278B2 (en) | Skin external preparation, wrinkle improvement promoter, sagging improvement promoter, matrix metalloproteinase gene expression inhibitor. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160822 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170613 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20170727 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170922 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20171003 |